Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM GANC	7.14e-05	5	54	2	GO:0004558
GeneOntologyMolecularFunction	alpha-glucosidase activity	MGAM GANC	1.49e-04	7	54	2	GO:0090599
GeneOntologyMolecularFunction	deacetylase activity	MIER3 NDST2 MIER1	1.72e-04	40	54	3	GO:0019213
GeneOntologyMolecularFunction	potassium channel inhibitor activity	WNK3 WNK2	3.89e-04	11	54	2	GO:0019870
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	MIER3 NDST2 CDADC1 MIER1	6.53e-04	146	54	4	GO:0016810
GeneOntologyMolecularFunction	glucosidase activity	MGAM GANC	7.37e-04	15	54	2	GO:0015926
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	MIER3 NDST2 MIER1	1.37e-03	81	54	3	GO:0016811
GeneOntologyMolecularFunction	histone deacetylase activity	MIER3 MIER1	1.91e-03	24	54	2	GO:0004407
GeneOntologyMolecularFunction	protein lysine deacetylase activity	MIER3 MIER1	2.07e-03	25	54	2	GO:0033558
GeneOntologyBiologicalProcess	maltose metabolic process	MGAM GANC	1.94e-05	3	53	2	GO:0000023
MousePheno	epididymis epithelium degeneration	BMP8B BMP8A	2.90e-05	3	44	2	MP:0004934
Domain	Kinase_OSR1/WNK_CCT	WNK3 WNK2	1.22e-04	6	54	2	IPR024678
Domain	OSR1_C	WNK3 WNK2	1.22e-04	6	54	2	PF12202
Domain	Glyco_hydro_31_AS	MGAM GANC	1.22e-04	6	54	2	IPR030458
Domain	Glyco_hydro_31	MGAM GANC	1.71e-04	7	54	2	IPR000322
Domain	Glyco_hydro_31	MGAM GANC	1.71e-04	7	54	2	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	MGAM GANC	1.71e-04	7	54	2	PS00129
Domain	ER_TARGET	HSP90B1 RCN1 RCN2	3.39e-04	47	54	3	PS00014
Domain	Inhibin_asu	BMP8B BMP8A	6.27e-04	13	54	2	IPR002405
Domain	ELM2	MIER3 MIER1	6.27e-04	13	54	2	PF01448
Domain	ELM2	MIER3 MIER1	6.27e-04	13	54	2	PS51156
Domain	ELM2_dom	MIER3 MIER1	6.27e-04	13	54	2	IPR000949
Domain	ELM2	MIER3 MIER1	6.27e-04	13	54	2	SM01189
Domain	Gal_mutarotase_SF_dom	MGAM GANC	1.09e-03	17	54	2	IPR011013
Domain	bZIP_2	CEBPD TEF	1.09e-03	17	54	2	PF07716
Domain	EF-hand_5	RCN1 RCN2	2.36e-03	25	54	2	PF13202
Domain	SANT_dom	MIER3 MIER1	2.55e-03	26	54	2	IPR017884
Domain	SANT	MIER3 MIER1	2.96e-03	28	54	2	PS51293
Domain	TGFb_propeptide	BMP8B BMP8A	2.96e-03	28	54	2	PF00688
Domain	TGF-b_N	BMP8B BMP8A	2.96e-03	28	54	2	IPR001111
Domain	TGF-beta-rel	BMP8B BMP8A	3.85e-03	32	54	2	IPR015615
Domain	TGFb_CS	BMP8B BMP8A	3.85e-03	32	54	2	IPR017948
Domain	Myb_DNA-binding	MIER3 MIER1	4.59e-03	35	54	2	PF00249
Domain	TGFB	BMP8B BMP8A	5.12e-03	37	54	2	SM00204
Domain	TGF-b_C	BMP8B BMP8A	5.12e-03	37	54	2	IPR001839
Domain	TGF_BETA_2	BMP8B BMP8A	5.12e-03	37	54	2	PS51362
Domain	TGF_beta	BMP8B BMP8A	5.12e-03	37	54	2	PF00019
Domain	TGF_BETA_1	BMP8B BMP8A	5.12e-03	37	54	2	PS00250
Domain	SANT	MIER3 MIER1	9.20e-03	50	54	2	SM00717
Domain	BRLZ	CEBPD TEF	9.92e-03	52	54	2	SM00338
Domain	SANT/Myb	MIER3 MIER1	9.92e-03	52	54	2	IPR001005
Domain	BZIP	CEBPD TEF	1.03e-02	53	54	2	PS50217
Domain	BZIP_BASIC	CEBPD TEF	1.03e-02	53	54	2	PS00036
Domain	Glycoside_hydrolase_SF	MGAM GANC	1.03e-02	53	54	2	IPR017853
Domain	bZIP	CEBPD TEF	1.07e-02	54	54	2	IPR004827
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	SBNO1 ZC3H4 CPSF6 G3BP2 RCN1 RCN2 BAZ1B BUB3 MIER1	6.87e-07	653	54	9	33742100
Pubmed	PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas.	PIM1 BCL6	2.37e-06	2	54	2	22451912
Pubmed	Human BMP8A suppresses luteinization of rat granulosa cells via the SMAD1/5/8 pathway.	BMP8B BMP8A	2.37e-06	2	54	2	31940275
Pubmed	Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis.	BMP8B BMP8A	2.37e-06	2	54	2	9463357
Pubmed	The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse.	BMP8B BMP8A	2.37e-06	2	54	2	8682296
Pubmed	The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells.	BMP8B BMP8A	2.37e-06	2	54	2	21277400
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CACTIN MDN1 MAPT ZC3H4 BAZ1B BUB3 MN1 MIER1 AGTPBP1	2.78e-06	774	54	9	15302935
Pubmed	The functional interactome landscape of the human histone deacetylase family.	MDN1 MIER3 RCN1 RCN2 BAZ1B MIER1	5.78e-06	289	54	6	23752268
Pubmed	Evidence that Mothers-against-dpp-related 1 (Madr1) plays a role in the initiation and maintenance of spermatogenesis in the mouse.	BMP8B BMP8A	7.09e-06	3	54	2	9076678
Pubmed	Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).	BMP8B BMP8A	7.09e-06	3	54	2	12925636
Pubmed	Requirement of Bmp8b for the generation of primordial germ cells in the mouse.	BMP8B BMP8A	7.09e-06	3	54	2	10894154
Pubmed	WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway.	WNK3 WNK2	7.09e-06	3	54	2	18768590
Pubmed	BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions.	BMP8B BMP8A	7.09e-06	3	54	2	22579288
Pubmed	Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis.	BMP8B BMP8A	7.09e-06	3	54	2	11784057
Pubmed	Estrogen mediated epithelial proliferation in the uterus is directed by stromal Fgf10 and Bmp8a.	BMP8B BMP8A	7.09e-06	3	54	2	25451979
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	NID2 CACTIN FAT1 MAPT ZC3H4 RCN1 RCN2 BAZ1B P3H4 AGTPBP1	7.37e-06	1116	54	10	31753913
Pubmed	Characterization and chromosomal localization of PTPRO, a novel receptor protein tyrosine phosphatase, expressed in hematopoietic stem cells.	BMP8B BMP8A	1.42e-05	4	54	2	9434160
Pubmed	Evidence that mouse Bmp8a (Op2) and Bmp8b are duplicated genes that play a role in spermatogenesis and placental development.	BMP8B BMP8A	1.42e-05	4	54	2	8843393
Pubmed	Axon morphogenesis and maintenance require an evolutionary conserved safeguard function of Wnk kinases antagonizing Sarm and Axed.	WNK3 WNK2	1.42e-05	4	54	2	34384519
Pubmed	Common variants at 12q15 and 12q24 are associated with infant head circumference.	SBNO1 MAPT	1.42e-05	4	54	2	22504419
Pubmed	Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.	PIM1 BCL6	1.42e-05	4	54	2	17476282
Pubmed	WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.	WNK3 WNK2	1.42e-05	4	54	2	11571656
Pubmed	Human hypertension caused by mutations in WNK kinases.	WNK3 WNK2	1.42e-05	4	54	2	11498583
Pubmed	The de novo synthesis of ubiquitin: identification of deubiquitinases acting on ubiquitin precursors.	USP5 OTULIN	2.36e-05	5	54	2	26235645
Pubmed	Differential HDAC1 and 2 Recruitment by Members of the MIER Family.	MIER3 MIER1	2.36e-05	5	54	2	28046085
Pubmed	Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation.	BMP8B BMP8A	3.54e-05	6	54	2	9878243
Pubmed	Colocalization of BMP 7 and BMP 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development.	BMP8B BMP8A	3.54e-05	6	54	2	7605753
Pubmed	A General in Vitro Assay for Studying Enzymatic Activities of the Ubiquitin System.	USP5 MAPT	3.54e-05	6	54	2	31951392
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	MDN1 CPSF6 G3BP2 BAZ1B RIOK2	4.46e-05	251	54	5	28077445
Pubmed	Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members.	WNK3 WNK2	4.94e-05	7	54	2	20525693
Pubmed	The Bmp8 gene is expressed in developing skeletal tissue and maps near the Achondroplasia locus on mouse chromosome 4.	BMP8B BMP8A	4.94e-05	7	54	2	9070944
Pubmed	Characterisation of the mouse diabetes susceptibilty locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat.	BMP8B BMP8A	4.94e-05	7	54	2	12107726
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ADCY4 HSP90B1 MDN1 SBNO1 CPSF6 PIM1 G3BP2 RCN2 BAZ1B BUB3	5.96e-05	1425	54	10	30948266
Pubmed	KLHL2 interacts with and ubiquitinates WNK kinases.	WNK3 WNK2	6.59e-05	8	54	2	23838290
Pubmed	The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.	WNK3 WNK2	6.59e-05	8	54	2	23387299
Pubmed	Gene structure and evolution of testicular haploid germ cell-specific genes, Oxct2a and Oxct2b.	BMP8B BMP8A	8.46e-05	9	54	2	15028287
Pubmed	Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis.	BMP8B BMP8A	8.46e-05	9	54	2	1460021
Pubmed	The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.	MGAM MYO5C	8.46e-05	9	54	2	25857663
Pubmed	Ermap, a gene coding for a novel erythroid specific adhesion/receptor membrane protein.	BMP8B BMP8A	1.29e-04	11	54	2	10721728
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MAGEA1 HSP90B1 MDN1 ZC3H4 CPSF6 RCN1 BAZ1B BUB3	1.36e-04	989	54	8	36424410
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	USP5 FAT1 MDN1 EFS	1.44e-04	170	54	4	23314748
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MAGEA1 HSP90B1 FAT1 CTSC RCN1 RCN2 BUB3 RIOK2 P3H4	1.59e-04	1297	54	9	33545068
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	USP5 HSP90B1 CPSF6 G3BP2 BAZ1B BUB3 TEF	1.60e-04	754	54	7	35906200
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FAT1 CEBPD ZC3H4 BAZ1B BMP8A	1.66e-04	332	54	5	37433992
Pubmed	Bmp7 regulates germ cell proliferation in mouse fetal gonads.	BMP8B BMP8A	1.83e-04	13	54	2	18391523
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	USP5 HSP90B1 MDN1 CPSF6 CTSC	1.95e-04	344	54	5	30333137
Pubmed	New Dyscalc loci for myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice.	BMP8B BMP8A	2.13e-04	14	54	2	11526197
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	MDN1 ZC3H4 CTSC BUB3 MIER1	2.50e-04	363	54	5	14691545
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	NPHS1 HSP90B1 EFS PIM1 CLEC7A BMP8A BCL6	2.75e-04	824	54	7	20237496
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	HSP90B1 MDN1 OTULIN CPSF6 G3BP2 BUB3	2.80e-04	582	54	6	20467437
Pubmed	Global comparative transcriptome analysis of cartilage formation in vivo.	BMP8B BMP8A	2.80e-04	16	54	2	19272164
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	USP5 HSP90B1 SBNO1 ZC3H4 CPSF6 G3BP2 RCN1 BUB3 RIOK2	3.03e-04	1415	54	9	28515276
Pubmed	Mili, a mammalian member of piwi family gene, is essential for spermatogenesis.	BMP8B BMP8A	3.17e-04	17	54	2	14736746
Pubmed	Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin.	HSP90B1 CTSC	3.17e-04	17	54	2	21795745
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	HSP90B1 MDN1 ZC3H4 G3BP2 RCN1 BAZ1B BUB3	3.24e-04	847	54	7	35850772
Pubmed	Dysfunction of programmed embryo senescence is linked to genetic developmental defects.	BMP8B BMP8A	3.56e-04	18	54	2	37017267
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	NID2 HSP90B1 FAT1 CPSF6 CTSC RCN2 MIER1 P3H4 LCLAT1	3.65e-04	1451	54	9	30550785
Pubmed	PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.	HSP90B1 MDN1 RCN1 BUB3	3.65e-04	217	54	4	31685992
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	USP5 HSP90B1 MDN1 ZC3H4 CPSF6 G3BP2 RCN1 RCN2	3.74e-04	1149	54	8	35446349
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	NID2 MDN1 CPSF6 RCN2	3.78e-04	219	54	4	31353912
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	HSP90B1 FAT1 RCN1 RCN2 BUB3	3.95e-04	401	54	5	25852190
Pubmed	Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.	PIM1 BCL6	4.42e-04	20	54	2	19336552
Pubmed	Neonatal Respiratory Failure with Retarded Perinatal Lung Maturation in Mice Caused by Reticulocalbin 3 Disruption.	RCN1 RCN2	4.42e-04	20	54	2	26252542
Pubmed	Regulation of the endosomal SNX27-retromer by OTULIN.	USP5 OTULIN	4.88e-04	21	54	2	31541095
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	USP5 HSP90B1 FAT1 CTSC RCN1 RCN2 NCAPH2 P3H4	5.01e-04	1201	54	8	35696571
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZNF317 MIER1 WNK3	5.29e-04	101	54	3	10997877
Pubmed	Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy.	PIM1 BCL6	5.36e-04	22	54	2	28334989
Pubmed	Mapping wild-type and R345W fibulin-3 intracellular interactomes.	HSP90B1 RCN1	5.36e-04	22	54	2	27777122
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	CACTIN USP5 FAT1 ZC3H4 CTSC NDST2 BCL6 AGTPBP1	5.41e-04	1215	54	8	15146197
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	ZC3H4 CPSF6 BAZ1B BUB3	6.31e-04	251	54	4	31076518
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	CACTIN HSP90B1 CPSF6 G3BP2 BUB3 RIOK2 MYO5C	6.39e-04	949	54	7	36574265
Pubmed	Osteoblast-specific expression of Panx3 is dispensable for postnatal bone remodeling.	BMP8B CLEC7A BMP8A	6.44e-04	108	54	3	31202927
Pubmed	Global landscape of HIV-human protein complexes.	HSP90B1 LIMD1 G3BP2 RCN1 RCN2	7.14e-04	457	54	5	22190034
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	HSP90B1 CPSF6 CTSC G3BP2 RCN2	7.57e-04	463	54	5	34901782
Pubmed	FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.	HSP90B1 OTULIN RCN1 RCN2 LCLAT1	7.94e-04	468	54	5	31056421
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CACTIN CRYBG2 ZC3H4 CPSF6 BUB3	8.02e-04	469	54	5	27634302
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	MAGEA1 HSP90B1 CPSF6 G3BP2 RCN1 RCN2	8.20e-04	714	54	6	28302793
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	LIMD1 MAPT ZC3H4 G3BP2 BUB3 AGTPBP1	8.81e-04	724	54	6	36232890
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	HSP90B1 MDN1 CPSF6 G3BP2 RCN2 BUB3	8.87e-04	725	54	6	27025967
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	ZC3H4 CPSF6 G3BP2 RCN2 BUB3	9.40e-04	486	54	5	30940648
Pubmed	Phosphorylated tau interactome in the human Alzheimer's disease brain.	USP5 HSP90B1 MAPT	9.83e-04	125	54	3	32812023
Pubmed	Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors.	HSP90B1 RCN2 MYO5C	9.83e-04	125	54	3	36030824
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	CACTIN ZC3H4 CPSF6 BAZ1B	9.86e-04	283	54	4	30585729
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HSP90B1 MDN1 ZC3H4 CPSF6 RCN1 BAZ1B MYO5C	9.96e-04	1024	54	7	24711643
Pubmed	SARS-CoV-2 nucleocapsid protein interacts with immunoregulators and stress granules and phase separates to form liquid droplets.	HSP90B1 G3BP2	1.00e-03	30	54	2	34780058
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	HSP90B1 RCN1	1.07e-03	31	54	2	19136429
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CACTIN CPSF6 CTSC G3BP2 RCN2 BUB3 RIOK2 AGTPBP1	1.18e-03	1371	54	8	36244648
Pubmed	Forkhead box a2 (FOXA2) is essential for uterine function and fertility.	BMP8B BMP8A	1.21e-03	33	54	2	28049832
Pubmed	Integrated Transcriptome and Network Analysis Reveals Spatiotemporal Dynamics of Calvarial Suturogenesis.	BMP8B BMP8A	1.21e-03	33	54	2	32640236
Pubmed	In silico prediction of physical protein interactions and characterization of interactome orphans.	MAPT PIM1 BCL6	1.25e-03	136	54	3	25402006
Pubmed	Proteomic analysis of the NOS2 interactome in human airway epithelial cells.	FAT1 RCN1 RCN2	1.31e-03	138	54	3	23438482
Pubmed	[IMAGE: molecular integration of the analysis of the human genome and its expression].	BMP8B WNK3	1.36e-03	35	54	2	7757816
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	FAT1 CPSF6 RCN1 RCN2 P3H4	1.41e-03	533	54	5	25544563
Pubmed	Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics.	G3BP2 P3H4	1.44e-03	36	54	2	15717329
Pubmed	Human transcription factor protein interaction networks.	FAT1 LIMD1 G3BP2 RCN1 RCN2 BAZ1B MIER1 MYO5C	1.54e-03	1429	54	8	35140242
Interaction	EP300 interactions	USP5 CEBPD SBNO1 MAPT ZC3H4 CPSF6 G3BP2 RCN1 RCN2 BAZ1B BCL6 BUB3 MN1 MIER1	1.34e-05	1401	54	14	int:EP300
Interaction	TMEM106B interactions	HSP90B1 FAT1 CTSC RCN1 RCN2 BUB3 P3H4	1.78e-05	309	54	7	int:TMEM106B
Interaction	TAFAZZIN interactions	NID2 BMP8B FAT1 NDST2 BMP8A P3H4	1.87e-05	207	54	6	int:TAFAZZIN
GeneFamily	Bone morphogenetic proteins\|Astacins	BMP8B BMP8A	2.10e-04	11	36	2	455
GeneFamily	C-type lectin domain family	CLEC7A CLEC16A	3.94e-03	47	36	2	494
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MIER3 MIER1	4.98e-03	53	36	2	532
ToppCell	distal-3-Hematologic-Plasma\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSP90B1 BMP8B PIM1 TENT5C PAIP2B	3.77e-06	194	54	5	d6e2e17732ad75604525fd65b2a3171e86cd01c7
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D3\|390C / Donor, Lineage, Cell class and subclass (all cells)	MGAM BMP8B PIM1 G3BP2	2.73e-05	143	54	4	10473c0f030d5ff760263042dc4b584787cb4a7f
ToppCell	Influenza_Severe-Neutrophil\|Influenza_Severe / Disease group and Cell class	MGAM BCL6 WNK2 MYO5C	4.35e-05	161	54	4	98c95b1b85d5427415af2ca8fb14849e97f6e8b5
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CEBPD MAPT PREX2 LCLAT1	4.56e-05	163	54	4	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	ICU-SEP-Lymphocyte-B-Plasmablast\|ICU-SEP / Disease, Lineage and Cell Type	BMP8B TENT5C BMP8A WNK2	4.89e-05	166	54	4	98ce43e14133418f676f1c88c001add9e28259a7
ToppCell	Influenza_Severe-Neutrophil\|World / Disease group and Cell class	MGAM CEBPD BCL6 WNK2	5.25e-05	169	54	4	6e8e2580e19c96bcf7fa6a6d8c183df65f428396
ToppCell	severe_influenza-Neutrophil\|World / disease group, cell group and cell class (v2)	MGAM CEBPD BCL6 WNK2	5.88e-05	174	54	4	f9f07436b7d3f190800cd85d229f007032f391e1
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HSP90B1 BMP8B TENT5C PAIP2B	6.85e-05	181	54	4	f7b08f662eb77ee7a777c6525ddc3195046aaf65
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT1 EFS RCN1 BMP8A	7.00e-05	182	54	4	193cb2df3d7ea4cb9a11390b92955e7d9b0a053a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAM CEBPD CLEC7A BCL6	7.15e-05	183	54	4	340621a8e720bd98da335f90598096833681834c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAM CEBPD CLEC7A BCL6	7.15e-05	183	54	4	75da8c05b6d636f434c5684e0166fed0de3547b4
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HSP90B1 BMP8B TENT5C BMP8A	7.61e-05	186	54	4	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MGAM CEBPD CLEC7A BCL6	7.77e-05	187	54	4	75bc05a0ba2727fecc236903ace792a28f3d3c9a
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MGAM CEBPD CLEC7A BCL6	7.77e-05	187	54	4	a0d59bf1043ff5a1e8110b39ecc2d3932675edd4
ToppCell	control-Myeloid-Neutrophils_4\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	7.93e-05	188	54	4	22d76c222fb0e3da08e10191af0090f14e03f2ad
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HSP90B1 BMP8B TENT5C BMP8A	7.93e-05	188	54	4	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	COVID-19_Severe-Myeloid_G-Neutrophil\|COVID-19_Severe / Disease group, lineage and cell class	MGAM CEBPD CLEC7A BCL6	8.10e-05	189	54	4	a62f4c445ede00d15b74bee65f4e4fb54cfd4d32
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MGAM CEBPD CLEC7A BCL6	8.10e-05	189	54	4	f6b2b4824505f0119a017fdb73c55418fb651645
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MGAM CEBPD CLEC7A BCL6	8.10e-05	189	54	4	db8e314ce95c32542bb4015a77032a33211fea0b
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSP90B1 EFS RCN1 MN1	8.26e-05	190	54	4	947807863a9b247c301c6cf63d6fd5a2c8018e66
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSP90B1 EFS RCN1 MN1	8.43e-05	191	54	4	db4943dd19207663fb9e27f8940fa4b06a933625
ToppCell	metastatic_Brain-T/NK_cells-Treg\|T/NK_cells / Location, Cell class and cell subclass	CTSC CLEC7A TENT5C MYO5C	8.60e-05	192	54	4	7c6f44716fc684b0297f266f04968e26fabdf6e3
ToppCell	mild-Lymphocytic-CD4_T_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	8.60e-05	192	54	4	4cd8f572e067bf5fe22f62fa868d7d332f097a8c
ToppCell	COPD-Myeloid-ncMonocyte\|COPD / Disease state, Lineage and Cell class	CEBPD LIMD1 CLEC7A AGTPBP1	8.78e-05	193	54	4	936ca95995599356b794fba32bfd82d8de339365
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MGAM CEBPD CLEC7A BCL6	8.95e-05	194	54	4	e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCell	control-Lymphocytic-CD4_T_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	8.95e-05	194	54	4	c2ae2ea848d78725455dcb6be9f1d8933745fa80
ToppCell	COVID_vent-Myeloid-Monocytic-Neutrophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MGAM CEBPD CLEC7A BCL6	8.95e-05	194	54	4	eb23b171e429165dd26a64377eae7fa2ce25f547
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPHS1 RCN1 WNK3 WNK2	8.95e-05	194	54	4	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 NID2 FAT1 CTSC	8.95e-05	194	54	4	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	mild-Myeloid-Neutrophils_3\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	9.13e-05	195	54	4	a1cfed0092debcc003eff6a62508556b7664d5e1
ToppCell	distal-Hematologic-Plasma-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BMP8B PIM1 TENT5C PAIP2B	9.13e-05	195	54	4	4280a5bc5ed9bb12e278b182e0be6cb88fa83d83
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT1 LIMD1 TENT5C WNK2	9.13e-05	195	54	4	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 FAT1 CEBPD CTSC	9.32e-05	196	54	4	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	distal-Hematologic-Plasma-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSP90B1 PIM1 TENT5C PAIP2B	9.32e-05	196	54	4	8201aded3c7109fae5e6ca12bac2076acc7bf070
ToppCell	proximal-3-Hematologic-Plasma\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSP90B1 BMP8B TENT5C PAIP2B	9.32e-05	196	54	4	1ca453582b5db8f1ea20a846e698c54edf0a1f25
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 FAT1 CEBPD CTSC	9.32e-05	196	54	4	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MGAM CEBPD CLEC7A BCL6	9.32e-05	196	54	4	ad193b231ff2f7c72590fab79919c179d5d2f327
ToppCell	proximal-Hematologic-Plasma-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSP90B1 BMP8B TENT5C PAIP2B	9.32e-05	196	54	4	f6e842b18765c2d923706cabb5d17efeff1da5aa
ToppCell	control-Others-Megakaryocytes\|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	9.32e-05	196	54	4	10d914f1612622f64ac71da04e1995a854a4bec9
ToppCell	distal-Hematologic-Plasma\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BMP8B PIM1 TENT5C PAIP2B	9.32e-05	196	54	4	2a11dc1e51c64af7705e1622a9da583a6634c563
ToppCell	proximal-Hematologic-Plasma\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSP90B1 BMP8B TENT5C PAIP2B	9.32e-05	196	54	4	621f112a71f3d82fd75da8addfb16d86f590fe33
ToppCell	mild-Myeloid-Neutrophils_4\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	9.32e-05	196	54	4	f8c98cded5550843322b1711e1a57c7e88cae861
ToppCell	mild-Myeloid-Neutrophils_2\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	9.32e-05	196	54	4	e9f30eb8a3915c3b2af009c832bff9b349b65ae5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 NID2 FAT1 CTSC	9.32e-05	196	54	4	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT1 CTSC BCL6 MYO5C	9.50e-05	197	54	4	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.50e-05	197	54	4	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RCN1 TENT5C WNK2 MYO5C	9.50e-05	197	54	4	d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5
ToppCell	severe-Lymphocytic-CD4_T_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	9.50e-05	197	54	4	3b71e523d8a68f131def17233385df371db70db5
ToppCell	10x_3'_v3-blood_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MGAM CEBPD CLEC7A AGTPBP1	9.50e-05	197	54	4	2d3547107c88c7443fc6425742694e13368a71f5
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RCN1 TENT5C WNK2 MYO5C	9.50e-05	197	54	4	80b05c8ad9c1edc5dea3236079372475431343fe
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.50e-05	197	54	4	63b63c6b2f842adb87bc83222ff86796bd9b58f6
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.50e-05	197	54	4	fb50903b87498b400c8e16e6a561b6d9458e5d97
ToppCell	severe-Others-Megakaryocytes\|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM CEBPD CLEC7A BCL6	9.50e-05	197	54	4	fc0864e2de2d9f99084586b467551b6da535d933
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.69e-05	198	54	4	1f956e369e00d37835095a001db4b62a79014532
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.69e-05	198	54	4	dc6fbad0ecdd057189f71afcdb6aca25207314a3
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPHS1 RCN1 WNK3 WNK2	9.69e-05	198	54	4	dd0465b45b02cb8edf0914d19afb52fcaaeb012c
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MGAM CEBPD BCL6 AGTPBP1	9.69e-05	198	54	4	df546a9afc0e15398f33c1b511c7281771f9aea0
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.69e-05	198	54	4	6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.88e-05	199	54	4	d65ee89d5c7e8ed693d58e6a6de09565840e11c5
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.88e-05	199	54	4	7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MGAM CEBPD CLEC7A BCL6	9.88e-05	199	54	4	0dde17381b8a95bfddb4d1052b13d33f37b05d13
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.88e-05	199	54	4	f2ad641f36c577ff7019e88ad6b73ed7e46d8c74
ToppCell	ASK454-Immune-B_cell\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	CEBPD CTSC CLEC7A BCL6	9.88e-05	199	54	4	b9b0ae81b9e7e35023c73d3b936e88167461ba54
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT1 RCN1 BMP8A P3H4	9.88e-05	199	54	4	bf138cc692df727e087d140c014149ee5da00d9d
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MGAM GRID2IP MYO5C	9.97e-05	74	54	3	ef4c9eafc794c7d50aef28b37d21b52d3c511499
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MGAM GRID2IP MYO5C	9.97e-05	74	54	3	6ecbdf4186039a031410e09ecd5afa66b6d5e2dc
ToppCell	390C-Fibroblasts-Fibroblast-H\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	HSP90B1 CEBPD CTSC RCN1	1.01e-04	200	54	4	019340e8b4b4944a49e14fdec7ce2954cbb8ba2e
ToppCell	severe-Neutrophil\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MGAM CEBPD CLEC7A BCL6	1.01e-04	200	54	4	f9af7e77a8483ab4ae708b55514e64f5420fa0c1
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 BCL6 MN1 PREX2	1.01e-04	200	54	4	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 BCL6 MN1 PREX2	1.01e-04	200	54	4	a91345f268f13170c27309333603eb82400c9947
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAT1 EFS BMP8A P3H4	1.01e-04	200	54	4	3c898e81444b001835c3f1bbc68183078701b135
ToppCell	390C-Fibroblasts-Fibroblast-H-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	HSP90B1 CEBPD CTSC RCN1	1.01e-04	200	54	4	b6f21f5cc137eddf6ba90e81cae791b57d88d9d7
ToppCell	severe-Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MGAM CEBPD CLEC7A BCL6	1.01e-04	200	54	4	f04d5951bac4dee47c22aaf7973312ca797f322e
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAT1 EFS BMP8A P3H4	1.01e-04	200	54	4	3eca8ffeb41b664fbdbbd70b375c5d953503ab29
ToppCell	COVID-19-COVID-19_Severe-Myeloid-Neutrophil\|COVID-19_Severe / Disease, condition lineage and cell class	MGAM CEBPD CLEC7A BCL6	1.01e-04	200	54	4	fec2660c9a9977b3b3a2eaed063b9049c0b07ff2
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 BCL6 MN1 PREX2	1.01e-04	200	54	4	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	mild-Others-Megakaryocytes\|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CEBPD CLEC7A BCL6	2.09e-04	95	54	3	74df0149882e2cd0d9aba0ef1ae4aac2cc1aeeac
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NPHS1 MDN1 CLEC16A	5.73e-04	134	54	3	64979e1a056b7406e1be39c5ebe2f8d731ac3c17
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAM CLEC7A BCL6	6.65e-04	141	54	3	9f26b2a5ccdf8762f16b673e59543b694fbacc10
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAM CLEC7A BCL6	6.93e-04	143	54	3	5d5ba2717126a0d4e4464f3604cb282cb977d5b2
ToppCell	Control-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HSP90B1 BMP8B TENT5C	7.21e-04	145	54	3	fe68582f5a15b9714cb84fa32ac880e13cb69895
ToppCell	facs-Aorta-Heart-24m-Myeloid-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTULIN CLEC7A TENT5C	8.26e-04	152	54	3	525d65c5c8e5580947367afdb1f6e68b49e9e5bb
ToppCell	facs-Lung-18m-Hematologic-myeloid-leukocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PIM1 CLEC7A BCL6	8.42e-04	153	54	3	8cc2667213bfac37545bb63181e88ef1f1834413
ToppCell	facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PIM1 CLEC7A BCL6	8.42e-04	153	54	3	596bb7cfd1c713708ce73df30d890a0233eae7f7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 NID2 FAT1	8.91e-04	156	54	3	dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 NID2 FAT1	8.91e-04	156	54	3	abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell	facs-Spleen-nan-3m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM CEBPD CLEC7A	8.91e-04	156	54	3	f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655
ToppCell	facs-Spleen-nan-3m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM CEBPD CLEC7A	8.91e-04	156	54	3	da4f35353a84d919e683554932f110e29568df33
ToppCell	facs-Spleen-nan-3m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM CEBPD CLEC7A	8.91e-04	156	54	3	f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1
ToppCell	343B-Lymphocytic-Plasma_cell-\|343B / Donor, Lineage, Cell class and subclass (all cells)	HSP90B1 TENT5C PAIP2B	9.07e-04	157	54	3	554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8
ToppCell	343B-Lymphocytic-Plasma_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	HSP90B1 TENT5C PAIP2B	9.07e-04	157	54	3	2cb3deb5313ce734710c601935ca318e4179077e
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACTIN AGTPBP1 MYO5C	9.24e-04	158	54	3	2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c
ToppCell	facs-Aorta-Heart-24m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTULIN PIM1 TENT5C	9.41e-04	159	54	3	443f6df4a88fa8755adcde4cc12575dff614ecb4
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	HSP90B1 TENT5C PAIP2B	9.41e-04	159	54	3	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	367C-Lymphocytic-ILC\|367C / Donor, Lineage, Cell class and subclass (all cells)	NPHS1 G3BP2 TENT5C	9.58e-04	160	54	3	f70ec054b6d51c1565e4a257cbe3c9537c0eb09f
ToppCell	LAM-Lymphoid-B-cell-2\|LAM / Condition, Lineage and Cell class	HSP90B1 TENT5C PAIP2B	9.58e-04	160	54	3	0060c2b3304f411c682aa2ba20bcf80f346d2403
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LIMD1 BMP8A PREX2	9.76e-04	161	54	3	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	PND01-03-samps\|World / Age Group, Lineage, Cell class and subclass	ADCY4 MDN1 PREX2	9.76e-04	161	54	3	1973b112d8d67aacc02751797d0148e7b53bfa66
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CEBPD CTSC CLEC7A	1.01e-03	163	54	3	a6e272e043859858084b8d4d96fa4ff9e6eca454
ToppCell	droplet-Fat-Gat\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM PIM1 CLEC7A	1.03e-03	164	54	3	c7ad946829c655038b33748dddd7d68c15489034
Drug	CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A	NPHS1 CRYBG2 LIMD1 G3BP2 CDADC1 PAIP2B	6.51e-06	194	54	6	7558_DN
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; HL60; HG-U133A	SBNO1 CPSF6 RCN2 BUB3 RIOK2 AGTPBP1	7.53e-06	199	54	6	2032_DN
Drug	callyspongynic acid	MGAM GANC	1.65e-05	3	54	2	CID000636783
Drug	IPG7F	MGAM GANC	1.65e-05	3	54	2	CID003083273
Drug	Pradimicin Q	MGAM GANC	1.65e-05	3	54	2	CID000073572
Drug	7-deoxy-6-epi-castanospermine	MGAM GANC	1.65e-05	3	54	2	CID000125391
Drug	AC1NUR2V	MGAM GANC	1.65e-05	3	54	2	CID005489114
Drug	3-nitro-4-(6-aminohexylamido)phenylboronic acid	MGAM GANC	1.65e-05	3	54	2	CID000133488
Drug	myrciaphenone B	MGAM GANC	3.30e-05	4	54	2	CID000183139
Drug	glycovir	MGAM GANC	3.30e-05	4	54	2	CID000060807
Drug	thiochroman-4-one	MGAM GANC	3.30e-05	4	54	2	CID000019048
Drug	2-deoxymaltose	MGAM GANC	3.30e-05	4	54	2	CID003081508
Drug	AC1L3RZ0	MGAM GANC	3.30e-05	4	54	2	CID000145814
Drug	NSC277293	MGAM GANC	3.30e-05	4	54	2	CID000321973
Drug	gamma-glutamyl-2-naphthylamide	MGAM GANC	3.30e-05	4	54	2	CID000164706
Drug	atalaphyllidine	MGAM GANC	3.30e-05	4	54	2	CID005479542
Drug	Thiram	USP5 FAT1 CEBPD SBNO1 CPSF6 PIM1 CTSC TENT5C	3.45e-05	533	54	8	ctd:D013893
Drug	tetrachlorophthalimide	MGAM GANC	5.50e-05	5	54	2	CID000074077
Drug	PCB 167	MGAM TEF	5.50e-05	5	54	2	CID000040479
Drug	(-)-Lentiginosine	MGAM GANC	5.50e-05	5	54	2	CID000130407
Drug	D-gluco-octenitol	MGAM GANC	5.50e-05	5	54	2	CID006438548
Drug	beta-D-glucopyranosyl azide	MGAM GANC	5.50e-05	5	54	2	CID000152302
Drug	pulmatin	MGAM GANC	5.50e-05	5	54	2	CID000442731
Drug	Ro 22-0654	MGAM GANC	5.50e-05	5	54	2	CID000133753
Drug	sodium amide	MGAM RCN1	5.50e-05	5	54	2	CID000024533
Drug	AC1L1IZ2	MGAM ADCY4 HSP90B1 PIM1 RIOK2 MYO5C	8.13e-05	304	54	6	CID000004795
Drug	AC1OCFTL	MGAM GANC	8.23e-05	6	54	2	CID006918743
Drug	conduritol aziridine	MGAM GANC	8.23e-05	6	54	2	CID000130051
Drug	AC1NSXES	MGAM GANC	8.23e-05	6	54	2	CID005318890
Drug	BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A	PIM1 BAZ1B PAIP2B NCAPH2 P3H4	9.61e-05	194	54	5	6876_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	MAPT PIM1 PAIP2B NCAPH2 BCL6	9.61e-05	194	54	5	1239_UP
Drug	Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	PIM1 CDADC1 TENT5C PAIP2B NCAPH2	1.01e-04	196	54	5	1479_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	NID2 CACTIN MAPT CDADC1 NCAPH2	1.01e-04	196	54	5	6309_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	CACTIN CRYBG2 PIM1 BAZ1B NCAPH2	1.01e-04	196	54	5	1658_UP
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CACTIN NDST2 CDADC1 TENT5C NCAPH2	1.03e-04	197	54	5	6012_DN
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CACTIN CRYBG2 EFS CDADC1 TEF	1.03e-04	197	54	5	6497_UP
Drug	Dimenhydrinate [523-87-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A	EFS MAPT CDADC1 PAIP2B NCAPH2	1.03e-04	197	54	5	5450_UP
Drug	Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; HL60; HT_HG-U133A	CACTIN USP5 CRYBG2 NCAPH2 BCL6	1.06e-04	198	54	5	1330_UP
Drug	Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A	PIM1 BAZ1B PAIP2B NCAPH2 P3H4	1.06e-04	198	54	5	2799_DN
Drug	vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A	NPHS1 CACTIN CRYBG2 LIMD1 CDADC1	1.06e-04	198	54	5	7556_DN
Drug	Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A	USP5 PIM1 NDST2 NCAPH2 PREX2	1.06e-04	198	54	5	7023_UP
Drug	Furazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A	PIM1 CLEC7A BMP8A BCL6 TEF	1.08e-04	199	54	5	3358_UP
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A	CACTIN MAPT BAZ1B NCAPH2 CLEC16A	1.08e-04	199	54	5	7421_DN
Drug	PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A	NID2 USP5 HSP90B1 G3BP2 NCAPH2	1.08e-04	199	54	5	7072_DN
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CACTIN MAPT PIM1 TENT5C NCAPH2	1.08e-04	199	54	5	6836_DN
Drug	3KBG5CNP	MGAM GANC	1.15e-04	7	54	2	CID003083250
Drug	myrciacitrin I	MGAM GANC	1.15e-04	7	54	2	CID000183137
Drug	Mor-502	MGAM GANC	1.15e-04	7	54	2	CID003080955
Drug	ND2001	MGAM GANC	1.15e-04	7	54	2	CID000160207
Drug	N-dodecylimidazole	MGAM GANC	1.15e-04	7	54	2	CID000078002
Drug	heptenitol	MGAM GANC	1.15e-04	7	54	2	CID000188267
Drug	VAL-TRP	MGAM GANC	1.15e-04	7	54	2	CID000168182
Drug	isomaltotetraose	MGAM GANC	1.15e-04	7	54	2	CID003080783
Drug	desmanthin-1	MGAM GANC	1.15e-04	7	54	2	CID005316590
Drug	cisapride	ADCY4 FAT1 CEBPD MAPT	1.45e-04	112	54	4	CID000002769
Drug	indeloxazine	MGAM GANC	1.53e-04	8	54	2	CID000003704
Drug	9 mM of H	MGAM GANC	1.53e-04	8	54	2	CID000130464
Drug	3,4,5-triCQA	MGAM GANC	1.53e-04	8	54	2	CID006440783
Drug	NSC636590	MGAM GANC	1.53e-04	8	54	2	CID000072285
Drug	AC1L6VJ8	MGAM GANC	1.53e-04	8	54	2	CID000300088
Drug	casuarictin	MGAM GANC	1.53e-04	8	54	2	CID000073644
Drug	AC1NSUE6	MGAM GANC	1.53e-04	8	54	2	CID005316558
Drug	N-dodecyl morpholine	MGAM GANC	1.53e-04	8	54	2	CID000073764
Drug	potassium bromide	MGAM HSP90B1 CTSC	1.78e-04	46	54	3	CID000253877
Drug	leucrose	MGAM GANC	1.97e-04	9	54	2	CID000165577
Drug	m265	MGAM GANC	1.97e-04	9	54	2	CID000074189
Drug	nectrisine	MGAM GANC	2.45e-04	10	54	2	CID000122106
Drug	AC1LCY75	MGAM GANC	2.45e-04	10	54	2	CID000639298
Drug	( )-Calystegine A3	MGAM GANC	2.45e-04	10	54	2	CID000183073
Drug	Glc)4	MGAM GANC	2.45e-04	10	54	2	CID000189098
Drug	Ro 20-0083	MGAM GANC	2.45e-04	10	54	2	CID003082332
Drug	AC1L3M0Q	MGAM GANC	2.45e-04	10	54	2	CID000118008
Drug	TAK-013	MGAM GANC	2.45e-04	10	54	2	CID003038517
Drug	desoxyrhaponticin	MGAM GANC	2.45e-04	10	54	2	CID004430533
Drug	trehazolin	MGAM GANC	2.45e-04	10	54	2	CID003081797
Drug	meso-erythritol	MGAM GANC MIER1	2.87e-04	54	54	3	CID000008998
Drug	glucosyl fluoride	MGAM GANC	3.00e-04	11	54	2	CID000150967
Drug	DDMU	CTSC TEF	3.00e-04	11	54	2	CID000098491
Drug	CNP-G5	MGAM GANC	3.00e-04	11	54	2	CID000127309
Drug	galactosylarabinose	MGAM GANC	3.00e-04	11	54	2	CID000193417
Drug	trehalulose	MGAM GANC	3.00e-04	11	54	2	CID000162104
Drug	AC1NUSO2	MGAM GANC	3.00e-04	11	54	2	CID005460006
Drug	nicotinoylprocaine	MGAM GANC	3.59e-04	12	54	2	CID000159667
Drug	AC1LCT6N	MGAM GANC	3.59e-04	12	54	2	CID000606283
Drug	scutellarein	MGAM GANC	3.59e-04	12	54	2	CID005281697
Drug	colestimide	MGAM GANC	4.24e-04	13	54	2	CID000065840
Drug	MDL 25,637	MGAM GANC	4.24e-04	13	54	2	CID000128548
Drug	valiolamine	MGAM GANC	4.24e-04	13	54	2	CID000174312
Drug	cast 3	MGAM GANC	4.24e-04	13	54	2	CID000072360
Drug	maltal	MGAM GANC	4.24e-04	13	54	2	CID000169427
Drug	methyl 1'-epiacarviosin	MGAM GANC	4.24e-04	13	54	2	CID000197426
Drug	isoacarbose	MGAM GANC	4.24e-04	13	54	2	CID000449165
Drug	galloylglucose	MGAM GANC	4.24e-04	13	54	2	CID000124375
Drug	NSC77009	MGAM GANC	4.24e-04	13	54	2	CID000253775
Drug	mannostatin A	MGAM GANC	4.24e-04	13	54	2	CID000124189
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK3 WNK2	4.73e-05	6	53	2	DOID:4479 (implicated_via_orthology)
Disease	nephrotic syndrome	NPHS1 BCL6 CLEC16A	2.87e-04	71	53	3	EFO_0004255
Disease	glucose homeostasis measurement, glucose effectiveness measurement	BCL6 MYO5C	3.27e-04	15	53	2	EFO_0006833, EFO_0006896
Disease	osteoarthritis	GRID2IP SBNO1 MAPT CPSF6	6.84e-04	222	53	4	MONDO_0005178
Disease	neutrophil percentage of leukocytes	CEBPD SBNO1 MAPT BCL6 TEF CLEC16A	7.67e-04	610	53	6	EFO_0007990
Disease	nephrotic syndrome (implicated_via_orthology)	NPHS1 FAT1	8.52e-04	24	53	2	DOID:1184 (implicated_via_orthology)
Disease	basophil percentage of leukocytes	CEBPD GANC CTSC BCL6	9.57e-04	243	53	4	EFO_0007992
Disease	diabetes mellitus (implicated_via_orthology)	BMP8B BMP8A	1.00e-03	26	53	2	DOID:9351 (implicated_via_orthology)
Disease	cortex volume change measurement, age at assessment	CTSC WNK2	1.16e-03	28	53	2	EFO_0008007, EFO_0021500
Disease	allergic disease	SBNO1 BCL6 TEF CLEC16A	1.19e-03	258	53	4	MONDO_0005271
Disease	asthma, Eczema, allergic rhinitis	OTULIN TEF CLEC16A	1.36e-03	121	53	3	EFO_0005854, HP_0000964, MONDO_0004979
Disease	CCL2 measurement	LIMD1 ZC3H4 CLEC16A	1.52e-03	126	53	3	EFO_0004749
Disease	allergic rhinitis	BCL6 CLEC16A MIER1	1.78e-03	133	53	3	EFO_0005854
Disease	COVID-19 symptoms measurement	LIMD1 MAPT	1.81e-03	35	53	2	EFO_0600019
Disease	monocyte count	CRYBG2 CEBPD CTSC TENT5C BCL6 MN1 MIER1 PREX2	2.32e-03	1320	53	8	EFO_0005091
Disease	Eczema	BCL6 TEF CLEC16A LCLAT1	2.33e-03	310	53	4	HP_0000964
Disease	unipolar depression, age at onset	FAT1 PAIP2B	2.36e-03	40	53	2	EFO_0003761, EFO_0004847
Disease	subiculum volume	MAPT WNK2	2.73e-03	43	53	2	EFO_0009399
Disease	overall survival, pancreatic carcinoma	PAIP2B PREX2	3.53e-03	49	53	2	EFO_0000638, EFO_0002618
Disease	neutrophil measurement	CTSC TENT5C BCL6	3.99e-03	177	53	3	EFO_0803548
Disease	urinary albumin to creatinine ratio	MGAM FAT1 CTSC	4.12e-03	179	53	3	EFO_0007778
Disease	IGFBP-3 measurement	CACTIN CLEC16A	4.27e-03	54	53	2	EFO_0004626

Protein segments in the cluster

Peptide	Gene	Start	Entry
DEAEDYYDVITHPMD	BAZ1B	1371	Q9UIG0
SYMYEMDDTEHPEDG	BUB3	296	O43684
AYAVEDAGMEHRDPY	ADCY4	421	Q8NFM4
VGSEYADFPHMDDKQ	CDADC1	371	Q9BWV3
MYEHLFPELVDDFQD	AGTPBP1	421	Q9UPW5
AFEHPEEVDYMTEFV	RCN2	176	Q14257
GFVDQDEYIADMFSH	RCN1	221	Q15293
DEYIADMFSHEENGP	RCN1	226	Q15293
LSGHDEKENPFAEYM	PAIP2B	21	Q9ULR5
YGGHEDFSKMIDEAE	RIMKLA	131	Q8IXN7
MSDYESGDDGHFEEV	FAT1	4561	Q14517
DEDMAFPGHLYDEVE	NPHS1	1166	O60500
MEDSAGEGATEFHDY	MDN1	4661	Q9NU22
MEVYDGREHSAYGEP	MAGEA1	221	P43355
LEREMDAHPKADYFG	LIMD1	456	Q9UGP4
PYDVQHADIDYMDER	MGAM	406	O43451
HFEDMIDYFCDIHEP	LCLAT1	181	Q6UWP7
VDAGFDEHDIPYDAM	GANC	381	Q8TET4
DFDPTAEMLVHDYDD	MIER3	21	Q7Z3K6
AFTHDMEVTFYPGEE	NID2	611	Q14112
SDDPMAYIHFTAEGE	HSP90B1	366	P14625
QCPAEHEEDMYRAAD	OTULIN	46	Q96BN8
LTPENDYEEMSFHDD	GRID2IP	701	A4D2P6
MADGVDHIDIYADVG	CPSF6	1	Q16630
GAAAPAMYDDESAID	CEBPD	46	P49716
VHNDMFRYEDEVFGD	G3BP2	126	Q9UN86
DPAVVLFEAMDFEGH	CRYBG2	1261	Q8N1P7
MGQLYEDSHEEDDFL	GABARAPL3	91	Q9BY60
YHAMAGDDDEDGAPA	BMP8A	81	Q7Z5Y6
HHGPMAVAFEVYDDF	CTSC	366	P53634
MEDDPAGHHNEYEGI	EFS	361	O43281
PEEARSDMHYSVAEG	BCL6	266	P41182
SAEDDDLAVEMHEPY	CACTIN	316	Q8WUQ7
LGDMFYDEDLADSLH	ETFBKMT	186	Q8IXQ9
YHAMAGDDDEDGAPA	BMP8B	81	P34820
EDEEEMGHAETYAEY	SBNO1	231	A3KN83
EFDPSADMLVHDFDD	MIER1	21	Q8N108
EGYEHMAESQGPESF	MN1	151	Q10571
LLYDMVCGDIPFEHD	PIM1	231	P11309
GESFHLEYMDLDEFL	TEF	91	Q10587
IGESMYGDFEEAFDH	TENT5C	211	Q5VWP2
MEYHPDLENLDEDGY	CLEC7A	1	Q9BXN2
DLGAADDFLEPEEYM	NCAPH2	431	Q6IBW4
FLDMVYHALDSPDDD	CLEC16A	481	Q2KHT3
EEEDFQPREEAMLYH	P3H4	346	Q92791
FYHTGTEEEDAGDDM	NDST2	361	P52849
QEFEVMEDHAGTYGL	MAPT	6	P10636
SYFHSDEMDSGDELP	PREX2	1131	Q70Z35
HVEDPASVYDEAMEL	RIOK2	201	Q9BVS4
GSMGGDHPEDEEDFY	ZC3H4	271	Q9UPT8
DGDAPDEIATYMVEH	WNK2	1221	Q9Y3S1
TEYAHLFEVFGMDPH	ZNF317	166	Q96PQ6
YDEDDMVLDPSLAEH	USP5	261	P45974
DVDGDAPEDIADYMV	WNK3	776	Q9BYP7
GDMDPHIFAVAEEAY	MYO5C	131	Q9NQX4